Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-10, Stock:PFE, The news for the past five days is as follows:
2021-06-03: NEWS1: U.S. COVID-19 cases hits a new low but ‘we still have gaps to close’: Doctor.NEWS2: CORRECTED-(OFFICIAL)-UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine.NEWS3: Pfizer (PFE) Down 3% Since Last Earnings Report: Can It Rebound?.NEWS4: China aims to vaccinate 80% of its 1.4 billion people by the end of 2021.NEWS5: Vulnerable people may need vaccine boosters this year, scientists say.
2021-06-04: NEWS1: Pfizer Stock Still Has Good Upside, Especially If the Dividend Yield Falls.NEWS2: 'We still need to go even above and beyond the 70% threshold’ on vaccinations: Doctor.NEWS3: 'We'll play our part in Q4,' Sanofi CEO says on COVID-19 vaccine.NEWS4: COVID SCIENCE-More unvaccinated U.S. adolescents hospitalized; myocarditis may be rare vaccine side effect in teens.NEWS5: Biden partners with small businesses in COVID-19 vaccination push.NEWS6: UPDATE 1-Canada negotiates option for an extra 3 million Pfizer COVID-19 doses - Trudeau.NEWS7: CDC director is 'concerned' about teens hospitalized for COVID-19, urges vaccination.NEWS8: UPDATE 1-Switzerland approves Pfizer/BioNTech COVID-19 vaccine for 12-15 year olds.NEWS9: Global COVID-19 cases top 172 million as WHO warns of possible third wave in Africa after 20% increase in infections in two weeks.NEWS10: Vaccine Stocks Call For Billions In Sales Even As Covid Resisters Dig In: IBD/TIPP Poll.NEWS11: Pfizer-BioNTech Covid-19 vaccine approved for 12 to 15-year-olds in the U.K..NEWS12: UPDATE 1-UK approves Pfizer/BioNTech COVID shot for 12- to 15-year-olds.NEWS13: The Stock Market Isn't Crashing, This Is Just the New Normal.NEWS14: UK approves Pfizer/BioNTech COVID shot for 12- to 15-year-olds.NEWS15: This 1 Factor May Mean Bigger Vaccine Orders for Pfizer and Moderna.NEWS16: Heart inflammation probed as possible rare side effect of COVID-19 vaccine for teens.NEWS17: Here’s a list of the best led big U.S. companies—and Facebook tops it.NEWS18: UK approves Pfizer jab for younger adolescents.
2021-06-07: NEWS1: These Vaccine Latecomers Could Still Win Big. Here's How.NEWS2: U.S. should be ‘very concerned’ as Delta variant spreads in Britain: Doctor.NEWS3: Safety Concerns, Lower Demand Interrupts Use of Johnson & Johnson COVID-19 Shot: Reuters.NEWS4: Doctor: Another Covid surge is a ‘potential that we have to acknowledge’.NEWS5: COVID-19 vaccines administered tops 300 million, as cases, deaths and hospitalizations keep falling.NEWS6: The Delta Virus Variant Has the World on Edge. What to Know..NEWS7: Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib.NEWS8: UPDATE 2-Moderna seeks EU, Canada approval for COVID-19 vaccine's use in teens.NEWS9: FOCUS-J&J vaccine drive stalls out in U.S after safety pause.NEWS10: How Did Moderna's COVID Vaccine Results in Teens Stack Up Against Pfizer's?.
2021-06-08: NEWS1: U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older.NEWS2: Sinovac, Pfizer/BioNtech COVID-19 vaccines prove highly effective in Uruguay -government.NEWS3: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS4: Retirees stuck in the middle of debate over drug-price reform.NEWS5: Pfizer/BioNTech Initiates COVID-19 Vaccine Trial In Children Below 12 Years: Reuters.NEWS6: U.S. response to COVID-19 has a greater list of failures than accomplishments: Expert.NEWS7: ClearBridge Investments Disposed its Pfizer Inc. (PFE) Stake, Here’s Why.NEWS8: New U.S. COVID-19 cases and deaths tick higher, while CDC’s ‘real world’ study shows Pfizer, Moderna vaccines reduce infection risk by 91%.NEWS9: This 1 Big Element May Push Moderna Ahead of Pfizer.NEWS10: UPDATE 2-Pfizer to test COVID-19 vaccine in larger group of children below 12.NEWS11: Moderna (MRNA) Seeks Approval for COVID-19 Vaccine in Teens.NEWS12: Biogen gets FDA approval for Alzheimer's treatment.NEWS13: Pfizer to start large study to test COVID-19 vaccine in children below 12.NEWS14: 2 Blue Chips to Buy Now for a Bear Market.
2021-06-09: NEWS1: Why BioNTech Blew Past the Market on Wednesday.NEWS2: “The beginning of the end is here for covid, vaccination is key”: Doctor.NEWS3: ‘Fertility is not going to be affected in any way’ by COVID-19 vaccine: Doctor.NEWS4: Biden administration will buy 500 million Pfizer vaccines to share globally.NEWS5: US STOCKS-S&P 500 teases record closing high as retail frenzy churns.NEWS6: Biden administration to buy 500 million Pfizer shots for other countries: report.NEWS7: UPDATE 5-U.S. to donate 500 million Pfizer vaccine doses to the world -sources.NEWS8: Biden Reportedly to Buy 500M Pfizer Shots for Low-Income Nations.NEWS9: 2 High-Yield Dividend Stocks for 2021.NEWS10: Pfizer (PFE) Gets FDA Nod for Pneumococcal Vaccine Prevnar 20.NEWS11: FDA Approves Pfizer’s New Pneumococcal Vaccine, Setting Up Clash With Merck.NEWS12: Pfizer’s PREVNAR 20 Vaccine Receives FDA Approval for Adults Aged 18 and Above.NEWS13: FDA Clears Pfizer's Prevnar 20 Conjugate Vaccine For Adults.NEWS14: What Investors Need to Know From Pfizer's Earnings Report.NEWS15: Why Pfizer and Moderna Could Soon Be Big Winners in a New $22 Billion Market.NEWS16: US to donate 500m doses of Pfizer’s Covid vaccine.

Answer: Rise